Refuerzo:

Si recibió la serie de vacunas Moderna:

Puede recibir una dosis de refuerzo de Janssen (Johnson & Johnson) o Pfizer 5 meses después de su segunda dosis o dosis adicional.

Si recibió la serie de vacunas de Pfizer:

Puede recibir una dosis de refuerzo de Janssen (Johnson & Johnson) o Pfizer 5 meses después de su segunda dosis o dosis adicional.
El refuerzo de Pfizer solo está disponible para personas mayores de 12 años.

Si recibió la vacuna Janssen (Johnson & Johnson):

Puede recibir una dosis de refuerzo de Janssen (Johnson & Johnson) o Pfizer 2 meses después de la vacunación.
El refuerzo de Janssen (Johnson & Johnson) solo está disponible para personas mayores de 18 años.

BOOSTER Shot:

If you received the Moderna vaccine series:

You can receive a booster dose of Janssen (Johnson & Johnson) or Pfizer 5 months after your second dose or additional dose.

If you received the Pfizer vaccine series:

You can receive a booster dose of Janssen (Johnson & Johnson) or Pfizer 5 months after your second dose or additional dose.
The Pfizer booster is only available for people who are 12 years of age and older.

If you received the Janssen (Johnson & Johnson) vaccination:

You can receive a booster dose of Janssen (Johnson & Johnson) or Pfizer 2 months after your vaccination.
The Janssen (Johnson & Johnson) booster is only available for people who are 18 years of age and older.

Si recibió la serie de vacunas de Pfizer:

• Puede recibir una dosis de refuerzo de Moderna, Janssen (Johnson & Johnson) o Pfizer 5 meses después de su segunda dosis o dosis adicional.
• El refuerzo de Pfizer solo está disponible para personas mayores de 12 años.

Si recibió la vacuna Janssen (Johnson & Johnson):
• Puede recibir una dosis de refuerzo de Moderna, Janssen (Johnson & Johnson) o Pfizer 2 meses después de la vacunación.
• El refuerzo de Janssen (Johnson & Johnson) solo está disponible para personas mayores de 18 años.

Pfizer (12-17) Additional Dose Qualifiers

Active cancer treatment for tumors or cancers of the blood
Organ transplant recipients who are taking medicine to suppress the immune system
Stem cell transplant recipients (within the last 2 years or taking immunosuppressive medications)
Moderate or severe primary immunodeficiency (such as DiGeorge syndrome, Wiskott-Aldrich syndrome)
Advanced or untreated HIV infection

Si recibió la vacuna Janssen (Johnson & Johnson):

• Puede recibir una dosis de refuerzo de Moderna, Janssen (Johnson & Johnson) o Pfizer 2 meses después de la vacunación.
• El refuerzo de Janssen (Johnson & Johnson) solo está disponible para personas mayores de 18 años.

Si recibió la serie de vacunas Moderna:

Puede recibir una dosis de refuerzo de Moderna, Janssen (Johnson & Johnson) o Pfizer 5 meses después de su segunda dosis o dosis adicional.
El refuerzo Moderna solo está disponible para personas mayores de 18 años.

Calificadores de dosis adicionales

Los estudios mostraron respuestas inmunitarias inadecuadas a solo dos dosis en personas con las siguientes condiciones:

Tratamiento oncológico activo para tumores o cánceres de la sangre
Receptores de trasplantes de órganos que toman medicamentos para inhibir el sistema inmunitario
Receptores de trasplantes de células madre (en los últimos 2 años o tomando medicamentos inmunosupresores)
Inmunodeficiencia primaria moderada o grave (como el síndrome de DiGeorge, el síndrome de Wiskott-Aldrich)
Infección avanzada o no tratada de VIH
Tratamiento activo con dosis altas de cortico-esteroides (p. ej., cortisona, prednisona) u otros medicamentos que pueden suprimir su respuesta inmunitaria.
Si tiene alguna pregunta sobre si debe recibir una dosis adicional, comuníquese con su proveedor de atención médica.

NOTA: Si no ha completado su serie de dos dosis, su dosis adicional se puede programar al recibir su segunda vacunación.

Qualifying Medical Condition

Cancer (current or in remission, including 9/11-related cancers);
Chronic kidney disease;
Pulmonary Disease, limited to, COPD (chronic obstructive pulmonary disease), asthma (moderate-to-severe), pulmonary fibrosis, cystic fibrosis, tuberculosis, and 9/11 related pulmonary diseases;
Intellectual and Developmental Disabilities including Down
Syndrome;
Heart conditions, including but not limited to heart failure, coronary artery disease, cardiomyopathies, or hypertension (high blood pressure);
Immunocompromised state (weakened immune system) including but not limited to solid organ transplant or from blood or bone marrow transplant, immune deficiencies, HIV, use of corticosteroids, use of other immune weakening medicines, or other causes;
Severe Obesity (BMI 40 kg/m2 or higher), Obesity (body mass index [BMI] of 30 kg/m2 or higher but < 40 kg/m2), Overweight (BMI of 25 kg/m2 or higher but < 30kg/m2);
Pregnant or recently pregnant;
Sickle cell disease or Thalassemia;
Type 1 or 2 diabetes mellitus;
Cerebrovascular disease (affects blood vessels and blood supply to the brain);
Neurologic conditions include but not limited to Alzheimer’s
Disease or dementia;
Liver disease limited to cirrhosis, non-alcoholic fatty liver disease, alcoholic liver disease, or autoimmune hepatitis;
Current or former smoker;
Substance use disorder,
Mental health disorders are limited to mood disorders including depression, schizophrenia spectrum disorders.

Qualifying Medical Condition

Cancer (current or in remission, including 9/11-related cancers);
Chronic kidney disease;
Pulmonary Disease, limited to, COPD (chronic obstructive pulmonary disease), asthma (moderate-to-severe), pulmonary fibrosis, cystic fibrosis, tuberculosis, and 9/11 related pulmonary diseases;
Intellectual and Developmental Disabilities including Down
Syndrome;
Heart conditions, including but not limited to heart failure, coronary artery disease, cardiomyopathies, or hypertension (high blood pressure);
Immunocompromised state (weakened immune system) including but not limited to solid organ transplant or from blood or bone marrow transplant, immune deficiencies, HIV, use of corticosteroids, use of other immune weakening medicines, or other causes;
Severe Obesity (BMI 40 kg/m2 or higher), Obesity (body mass index [BMI] of 30 kg/m2 or higher but < 40 kg/m2), Overweight (BMI of 25 kg/m2 or higher but < 30kg/m2);
Pregnant or recently pregnant;
Sickle cell disease or Thalassemia;
Type 1 or 2 diabetes mellitus;
Cerebrovascular disease (affects blood vessels and blood supply to the brain);
Neurologic conditions include but not limited to Alzheimer’s
Disease or dementia;
Liver disease limited to cirrhosis, non-alcoholic fatty liver disease, alcoholic liver disease, or autoimmune hepatitis;
Current or former smoker;
Substance use disorder,
Mental health disorders are limited to mood disorders including depression, schizophrenia spectrum disorders.

Additional Dose Qualifiers

Studies showed inadequate immune responses to only two doses in people with the following conditions:

Active cancer treatment for tumors or cancers of the blood
Organ transplant recipients who are taking medicine to suppress the immune system
Stem cell transplant recipients (within the last 2 years or taking immunosuppressive medications)
Moderate or severe primary immunodeficiency (such as DiGeorge syndrome, Wiskott-Aldrich syndrome)
Advanced or untreated HIV infection
Active treatment with high-dose corticosteroids (e.g. cortisone, prednisone) or other drugs that may suppress your immune response.
If you have a question about whether you should receive an additional dose, please contact your health care provider.

NOTE: If you have not completed your two-dose series, your additional dose can be scheduled at the completion of your second vaccination.

Putting Telehealth to work at your health center or medical practice.

Telehealth is the future.

More medical practices are using it, and patients want it.
An article in Forbes magazine predicts that telehealth visits will double by 2020.

Patients want Telehealth Services

In the Telehealth Index 2015 Survey, 76% of patients said that access to healthcare services is more important to them than the need for human interactions with healthcare providers. In the same poll, 70% of patients say they are comfortable communicating with their healthcare providers via text, email or videos.

The survey also found that:

20% of consumers would switch their current primary care provider (PCP) to one that offers telehealth visits
65% of patients surveyed are interested in seeing their PCP over video.
Parents with children under 18 are even more likely to say they’re interested in telehealth.

LEARN MORE HERE

Partnering with Finger Lakes Community Health telehealth services.

Why should you consider becoming a telehealth provider? Perhaps you’re a specialist who would like to build your practice by connecting to patients in rural communities. As an experienced provider of telehealth services, Finger Lakes Community Health can make that happen.

We’ve been implementing telehealth for our patients for more than ten years. In addition to patient benefits, we’ve seen significant cost savings and a better continuum of care. Patients save time and money by not having to travel, use gas, or take off additional time from work. Medical practices build strong relationships with collaborating providers, allowing the clinical team to be on the same page with a patient’s treatment plan. This also reduces the duplication of work.

Helpful resources to better understand Telehealth

Difference between Telehealth and Telemedicine

Jennifer’s story on YouTube

Telemedicine, It’s a No Brainer. 1 minute.
What is Telemedicine. 2 minutes.

Refuerzo:

Si recibió la serie de vacunas Moderna: